메뉴 건너뛰기




Volumn 30, Issue 10, 2015, Pages 1649-1656

Adherence to antihypertensive medications: Is prescribing the right pill enough?

Author keywords

adherence; antihypertensive drugs; compliance

Indexed keywords

ANTIHYPERTENSIVE AGENT;

EID: 84943376845     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu330     Document Type: Review
Times cited : (25)

References (82)
  • 1
    • 84893651437 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2014 update: A report from the American Heart Association
    • Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014; 129: e28-e292
    • (2014) Circulation , vol.129 , pp. e28-e292
    • Go, A.S.1    Mozaffarian, D.2    Roger, V.L.3
  • 3
    • 84893549987 scopus 로고    scopus 로고
    • 2014 evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the eighth joint national committee (jnc 8
    • James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) JAMA 2014; 311: 507-520
    • (2014) Jama , vol.311 , pp. 507-520
    • James, P.A.1    Oparil, S.2    Carter, B.L.3
  • 4
    • 84855353573 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2012 update: A report from the American Heart Association
    • Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220
    • (2012) Circulation , vol.125 , pp. e2-e220
    • Roger, V.L.1    Go, A.S.2    Lloyd-Jones, D.M.3
  • 5
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
    • Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42: 1206-1252
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 6
    • 0034627183 scopus 로고    scopus 로고
    • Effects of ace inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: Results of prospectively designed overviews of randomised trials blood pressure lowering treatment trialists' collaboration
    • Neal B, MacMahon S, Chapman N, et al. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet 2000; 356: 1955-1964
    • (2000) Lancet , vol.356 , pp. 1955-1964
    • Neal, B.1    MacMahon, S.2    Chapman, N.3
  • 7
    • 0034635838 scopus 로고    scopus 로고
    • Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials
    • Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet 2000; 355: 865-872
    • (2000) Lancet , vol.355 , pp. 865-872
    • Staessen, J.A.1    Gasowski, J.2    Wang, J.G.3
  • 8
    • 84859700263 scopus 로고    scopus 로고
    • Guidance for Industry U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Available at 20 July 2014, date last accessed
    • Guidance for Industry. Hypertension indication: drug labeling for cardiovascular outcome claims. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER) Available at: http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInformation/Guidances/ucm075072.pdf. (20 July 2014, date last accessed) 2011
    • (2011) Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims
  • 9
    • 0344373794 scopus 로고    scopus 로고
    • Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhat
    • Officers A Coordinators for the ACRGTA Lipid-Lowering Treatment to Prevent Heart Attack Trial
    • Officers A, Coordinators for the ACRGTA, Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 2002; 288: 2981-2997
    • (2002) Jama , vol.288 , pp. 2981-2997
  • 10
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359: 2417-2428
    • (2008) N Engl J Med , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 11
    • 77951469747 scopus 로고    scopus 로고
    • Hypertension epidemiology and economic burden: Refining risk assessment to lower costs
    • Cohen JD. Hypertension epidemiology and economic burden: refining risk assessment to lower costs. Manag Care 2009; 18: 51-58
    • (2009) Manag Care , vol.18 , pp. 51-58
    • Cohen, J.D.1
  • 12
    • 0014200585 scopus 로고
    • Results in patients with diastolic blood pressures averaging 115 through 129 mmhg
    • Effects of treatment on morbidity in hypertension
    • Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mmHg. JAMA 1967; 202: 1028-1034
    • (1967) Jama , vol.202 , pp. 1028-1034
  • 13
    • 0015227657 scopus 로고
    • The chemotherapy of hypertension
    • Freis ED. The chemotherapy of hypertension. JAMA 1971; 218: 1009-1015
    • (1971) Jama , vol.218 , pp. 1009-1015
    • Freis, E.D.1
  • 14
    • 0015912563 scopus 로고
    • Drug therapy: Patient compliance
    • Blackwell B. Drug therapy: patient compliance. N Engl J Med 1973; 289: 249-252
    • (1973) N Engl J Med , vol.289 , pp. 249-252
    • Blackwell, B.1
  • 15
    • 33646835918 scopus 로고    scopus 로고
    • Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice
    • Burke TA, Sturkenboom MC, Lu SE, et al. Discontinuation of antihypertensive drugs among newly diagnosed hypertensive patients in UK general practice. J Hypertens 2006; 24: 1193-1200
    • (2006) J Hypertens , vol.24 , pp. 1193-1200
    • Burke, T.A.1    Sturkenboom, M.C.2    Lu, S.E.3
  • 16
    • 67650651982 scopus 로고    scopus 로고
    • Improving outcomes in hypertensive patients: Focus on adherence and persistence with antihypertensive therapy
    • Elliott WJ. Improving outcomes in hypertensive patients: focus on adherence and persistence with antihypertensive therapy. J Clin Hypertens (Greenwich) 2009; 11: 376-382
    • (2009) J Clin Hypertens (Greenwich , vol.11 , pp. 376-382
    • Elliott, W.J.1
  • 17
    • 0039607154 scopus 로고
    • Compliance with medical regimens: A panel study
    • Davis MS, Eichhorn RL. Compliance with medical regimens: a panel study. J Health Hum Behav 1963; 4: 240-249
    • (1963) J Health Hum Behav , vol.4 , pp. 240-249
    • Davis, M.S.1    Eichhorn, R.L.2
  • 18
    • 67649523031 scopus 로고    scopus 로고
    • Medication adherence: Its importance in cardiovascular outcomes
    • Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-3035
    • (2009) Circulation , vol.119 , pp. 3028-3035
    • Ho, P.M.1    Bryson, C.L.2    Rumsfeld, J.S.3
  • 19
    • 0142017677 scopus 로고    scopus 로고
    • Geneva World Health Organization
    • Adherence to Long Term Therapies: Evidence for Action. Geneva: World Health Organization 2003; https://http://www.who.int/chornic-conditions/en/adherence-report.pdf
    • (2003) Adherence to Long Term Therapies: Evidence for Action
  • 20
    • 38549098101 scopus 로고    scopus 로고
    • Medication compliance and persistence: Terminology and definitions
    • Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health 2008; 11: 44-47
    • (2008) Value Health , vol.11 , pp. 44-47
    • Cramer, J.A.1    Roy, A.2    Burrell, A.3
  • 21
    • 0034515494 scopus 로고    scopus 로고
    • Predictors of long-term persistence on statins in a subsidized clinical population
    • Catalan VS, LeLorier J. Predictors of long-term persistence on statins in a subsidized clinical population. Value Health 2000; 3: 417-426
    • (2000) Value Health , vol.3 , pp. 417-426
    • Catalan, V.S.1    LeLorier, J.2
  • 22
    • 25444477545 scopus 로고    scopus 로고
    • Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
    • Cramer JA, Amonkar MM, Hebborn A, et al. Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. Curr Med Res Opin 2005; 21: 1453-1460
    • (2005) Curr Med Res Opin , vol.21 , pp. 1453-1460
    • Cramer, J.A.1    Amonkar, M.M.2    Hebborn, A.3
  • 23
  • 24
    • 38549086933 scopus 로고    scopus 로고
    • The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke
    • Breekveldt-Postma NS, Penning-van Beest FJ, Siiskonen SJ, et al. The effect of discontinuation of antihypertensives on the risk of acute myocardial infarction and stroke. Curr Med Res Opin 2008; 24: 121-127
    • (2008) Curr Med Res Opin , vol.24 , pp. 121-127
    • Breekveldt-Postma, N.S.1    Penning-Van Beest, F.J.2    Siiskonen, S.J.3
  • 25
    • 79952910927 scopus 로고    scopus 로고
    • Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients
    • Esposti LD, Saragoni S, Benemei S, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res 2011; 3: 47-54
    • (2011) Clinicoecon Outcomes Res , vol.3 , pp. 47-54
    • Esposti, L.D.1    Saragoni, S.2    Benemei, S.3
  • 26
    • 60549087524 scopus 로고    scopus 로고
    • Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention
    • Kettani FZ, Dragomir A, Cote R, et al. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention. Stroke 2009; 40: 213-220
    • (2009) Stroke , vol.40 , pp. 213-220
    • Kettani, F.Z.1    Dragomir, A.2    Cote, R.3
  • 27
    • 84883465807 scopus 로고    scopus 로고
    • Adherence to antihypertensive agents improves risk reduction of end-stage renal disease
    • Roy L, White-Guay B, Dorais M, et al. Adherence to antihypertensive agents improves risk reduction of end-stage renal disease. Kidney Int 2013; 84: 570-577
    • (2013) Kidney Int , vol.84 , pp. 570-577
    • Roy, L.1    White-Guay, B.2    Dorais, M.3
  • 28
    • 33644548016 scopus 로고    scopus 로고
    • Long-term compliance with salt restriction in Japanese hypertensive patients
    • Ohta Y, Tsuchihashi T, Onaka U, et al. Long-term compliance with salt restriction in Japanese hypertensive patients. Hypertens Res 2005; 28: 953-957
    • (2005) Hypertens Res , vol.28 , pp. 953-957
    • Ohta, Y.1    Tsuchihashi, T.2    Onaka, U.3
  • 29
    • 0031267929 scopus 로고    scopus 로고
    • Enhancement of compliance among patients with hypertension
    • Patton K, Meyers J, Lewis BE. Enhancement of compliance among patients with hypertension. Am J Manag Care 1997; 3: 1693-1698
    • (1997) Am J Manag Care , vol.3 , pp. 1693-1698
    • Patton, K.1    Meyers, J.2    Lewis, B.E.3
  • 30
    • 65549132913 scopus 로고    scopus 로고
    • The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations
    • Uzun S, Kara B, YokusogluMet al. The assessment of adherence of hypertensive individuals to treatment and lifestyle change recommendations. Anadolu Kardiyol Derg 2009; 9: 102-109
    • (2009) Anadolu Kardiyol Derg , vol.9 , pp. 102-109
    • Uzun, S.1    Kara, B.2    Yokusoglu, M.3
  • 31
    • 84900302482 scopus 로고    scopus 로고
    • High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (hp lc-ms/ms) urine analysis
    • Tomaszewski M, White C, Patel P, et al. High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis. Heart 2014; 100: 855-861
    • (2014) Heart , vol.100 , pp. 855-861
    • Tomaszewski, M.1    White, C.2    Patel, P.3
  • 32
    • 78751649486 scopus 로고    scopus 로고
    • Improving the measurement of self-reported medication nonadherence: Response to authors
    • discussion 258-263
    • Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol 2011; 64: 255-257; discussion 258-263
    • (2011) J Clin Epidemiol , vol.64 , pp. 255-257
    • Morisky, D.E.1    DiMatteo, M.R.2
  • 33
    • 49349115364 scopus 로고    scopus 로고
    • Predictive validity of a medication adherence measure in an outpatient setting
    • Morisky DE, Ang A, Krousel-Wood M, et al. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008; 10: 348-354
    • (2008) J Clin Hypertens (Greenwich , vol.10 , pp. 348-354
    • Morisky, D.E.1    Ang, A.2    Krousel-Wood, M.3
  • 34
    • 0030940351 scopus 로고    scopus 로고
    • The electronic medication event monitor lessons for pharmacotherapy
    • Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 1997; 32: 345-356
    • (1997) Clin Pharmacokinet , vol.32 , pp. 345-356
    • Urquhart, J.1
  • 35
    • 33846468943 scopus 로고    scopus 로고
    • A checklist for medication compliance and persistence studies using retrospective databases
    • Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health 2007; 10: 3-12
    • (2007) Value Health , vol.10 , pp. 3-12
    • Peterson, A.M.1    Nau, D.P.2    Cramer, J.A.3
  • 36
    • 67650828614 scopus 로고    scopus 로고
    • Measuring concurrent adherence to multiple related medications
    • Choudhry NK, Shrank WH, Levin RL, et al. Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009; 15: 457-464
    • (2009) Am J Manag Care , vol.15 , pp. 457-464
    • Choudhry, N.K.1    Shrank, W.H.2    Levin, R.L.3
  • 37
    • 58549094914 scopus 로고    scopus 로고
    • Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication
    • Martin BC, Wiley-Exley EK, Richards S, et al. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother 2009; 43: 36-44
    • (2009) Ann Pharmacother , vol.43 , pp. 36-44
    • Martin, B.C.1    Wiley-Exley, E.K.2    Richards, S.3
  • 38
    • 33750047541 scopus 로고    scopus 로고
    • Toward a standard definition and measurement of persistence with drug therapy: Examples from research on statin and antihypertensive utilization
    • discussion 1410
    • Caetano PA, Lam JM, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther 2006; 28: 1411-1424; discussion 1410
    • (2006) Clin Ther , vol.28 , pp. 1411-1424
    • Caetano, P.A.1    Lam, J.M.2    Morgan, S.G.3
  • 39
    • 84922391679 scopus 로고    scopus 로고
    • Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans
    • Gosmanova EO, Lu JL, Streja E, et al. Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans Hypertension 2014; 64: 951-957
    • (2014) Hypertension , vol.64 , pp. 951-957
    • Gosmanova, E.O.1    Lu, J.L.2    Streja, E.3
  • 40
    • 33747410924 scopus 로고    scopus 로고
    • Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations
    • Bramley TJ, Gerbino PP, Nightengale BS, et al. Relationship of blood pressure control to adherence with antihypertensive monotherapy in 13 managed care organizations. J Manag Care Pharm 2006; 12: 239-245
    • (2006) J Manag Care Pharm , vol.12 , pp. 239-245
    • Bramley, T.J.1    Gerbino, P.P.2    Nightengale, B.S.3
  • 42
    • 0025338414 scopus 로고
    • On white-coat effects and the electronic monitoring of compliance
    • Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-1378
    • (1990) Arch Intern Med , vol.150 , pp. 1377-1378
    • Feinstein, A.R.1
  • 43
    • 25144446775 scopus 로고    scopus 로고
    • Strategies to enhance patient adherence: Making it simple
    • Atreja A, Bellam N, Levy SR. Strategies to enhance patient adherence: making it simple. MedGenMed 2005; 7: 4
    • (2005) MedGenMed , vol.7 , pp. 4
    • Atreja, A.1    Bellam, N.2    Levy, S.R.3
  • 44
    • 20444362063 scopus 로고    scopus 로고
    • Improving adherence to treatment for hypertension
    • Domino FJ. Improving adherence to treatment for hypertension. Am Fam Physician 2005; 71: 2089-2090
    • (2005) Am Fam Physician , vol.71 , pp. 2089-2090
    • Domino, F.J.1
  • 45
    • 0036719562 scopus 로고    scopus 로고
    • Patient adherence and medical treatment outcomes: A meta-analysis
    • DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis.Med Care 2002; 40: 794-811
    • (2002) Med Care , vol.40 , pp. 794-811
    • Di Matteo, M.R.1    Giordani, P.J.2    Lepper, H.S.3
  • 46
    • 65949122472 scopus 로고    scopus 로고
    • A review of studies of adherence with antihypertensive drugs using prescription databases
    • Fitz-Simon N, Bennett K, Feely J. A review of studies of adherence with antihypertensive drugs using prescription databases. Ther Clin Risk Manag 2005; 1: 93-106
    • (2005) Ther Clin Risk Manag , vol.1 , pp. 93-106
    • Fitz-Simon, N.1    Bennett, K.2    Feely, J.3
  • 47
    • 0030806211 scopus 로고    scopus 로고
    • The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: Results from a population-based study in the elderly
    • Monane M, Bohn RL, Gurwitz JH, et al. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997; 10: 697-704
    • (1997) Am J Hypertens , vol.10 , pp. 697-704
    • Monane, M.1    Bohn, R.L.2    Gurwitz, J.H.3
  • 48
    • 1542440031 scopus 로고    scopus 로고
    • Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy
    • Taylor AA, Shoheiber O. Adherence to antihypertensive therapy with fixed-dose amlodipine besylate/benazepril HCl versus comparable component-based therapy. Congest Heart Fail 2003; 9: 324-332
    • (2003) Congest Heart Fail , vol.9 , pp. 324-332
    • Taylor, A.A.1    Shoheiber, O.2
  • 49
    • 29244462820 scopus 로고    scopus 로고
    • Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: A retrospective cohort study in primary care
    • Mazzaglia G, Mantovani LG, Sturkenboom MC, et al. Patterns of persistence with antihypertensive medications in newly diagnosed hypertensive patients in Italy: a retrospective cohort study in primary care. J Hypertens 2005; 23: 2093-2100
    • (2005) J Hypertens , vol.23 , pp. 2093-2100
    • Mazzaglia, G.1    Mantovani, L.G.2    Sturkenboom, M.C.3
  • 50
    • 28844436931 scopus 로고    scopus 로고
    • Rate and determinants of 10-year persistence with antihypertensive drugs
    • Van Wijk BL, Klungel OH, Heerdink ER, et al. Rate and determinants of 10-year persistence with antihypertensive drugs. J Hypertens 2005; 23: 2101-2107
    • (2005) J Hypertens , vol.23 , pp. 2101-2107
    • Van Wijk, B.L.1    Klungel, O.H.2    Heerdink, E.R.3
  • 51
    • 44349111871 scopus 로고    scopus 로고
    • Adherence to prescribed antihypertensive drug treatments: Longitudinal study of electronically compiled dosing histories
    • Vrijens B, Vincze G, Kristanto P, et al. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ 2008; 336: 1114-1117
    • (2008) Bmj , vol.336 , pp. 1114-1117
    • Vrijens, B.1    Vincze, G.2    Kristanto, P.3
  • 52
    • 0031659477 scopus 로고    scopus 로고
    • Continuation of initial antihypertensive medication after 1 year of therapy
    • Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998; 20: 671-681
    • (1998) Clin Ther , vol.20 , pp. 671-681
    • Bloom, B.S.1
  • 53
    • 0033547740 scopus 로고    scopus 로고
    • Persistence with treatment for hypertension in actual practice
    • Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ 1999; 160: 31-37
    • (1999) Cmaj , vol.160 , pp. 31-37
    • Caro, J.J.1    Salas, M.2    Speckman, J.L.3
  • 54
    • 0031427407 scopus 로고    scopus 로고
    • Variations in compliance among hypertensive patients by drug class: Implications for health care costs
    • discussion 1424-1445
    • Rizzo JA, Simons WR. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997; 19: 1446-1457; discussion 1424-1445
    • (1997) Clin Ther , vol.19 , pp. 1446-1457
    • Rizzo, J.A.1    Simons, W.R.2
  • 55
    • 84891561464 scopus 로고    scopus 로고
    • Excess dietary sodium and inadequate potassium intake by hypertensive patients in Italy: Results of the minisal-siia study program
    • Galletti F, Agabiti-Rosei E, Bernini G, et al. Excess dietary sodium and inadequate potassium intake by hypertensive patients in Italy: results of the MINISAL-SIIA study program. J Hypertens 2014; 32: 48-56
    • (2014) J Hypertens , vol.32 , pp. 48-56
    • Galletti, F.1    Agabiti-Rosei, E.2    Bernini, G.3
  • 56
    • 31544432032 scopus 로고    scopus 로고
    • Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention
    • De Nicola L, Minutolo R, Chiodini P, et al. Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention. Kidney Int 2006; 69: 538-545
    • (2006) Kidney Int , vol.69 , pp. 538-545
    • De Nicola, L.1    Minutolo, R.2    Chiodini, P.3
  • 57
    • 70350246278 scopus 로고    scopus 로고
    • Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients
    • Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation 2009; 120: 1598-1605
    • (2009) Circulation , vol.120 , pp. 1598-1605
    • Mazzaglia, G.1    Ambrosioni, E.2    Alacqua, M.3
  • 58
    • 84885965367 scopus 로고    scopus 로고
    • Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences
    • Chowdhury R, Khan H, Heydon E, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013; 34: 2940-2948
    • (2013) Eur Heart J , vol.34 , pp. 2940-2948
    • Chowdhury, R.1    Khan, H.2    Heydon, E.3
  • 59
    • 49249106417 scopus 로고    scopus 로고
    • Resistant hypertension: Diagnosis, evaluation, and treatment a scientific statement from the American Heart Association professional education committee of the council for high blood pressure research
    • Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51: 1403-1419
    • (2008) Hypertension , vol.51 , pp. 1403-1419
    • Calhoun, D.A.1    Jones, D.2    Textor, S.3
  • 60
    • 84898731305 scopus 로고    scopus 로고
    • A controlled trial of renal denervation for resistant hypertension
    • Bhatt DL, Kandzari DE, O'Neill WW, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014; 370: 1393-1401
    • (2014) N Engl J Med , vol.370 , pp. 1393-1401
    • Bhatt, D.L.1    Kandzari, D.E.2    O'Neill, W.W.3
  • 61
    • 85127326105 scopus 로고
    • Treatment adherence in hypertension: Problems and research
    • van Veen WA. Treatment adherence in hypertension: problems and research. J R Coll Gen Pract Occas Pap 1980; 12: 22-25
    • (1980) J R Coll Gen Pract Occas Pap , vol.12 , pp. 22-25
    • Van Veen, W.A.1
  • 62
    • 84877951150 scopus 로고    scopus 로고
    • Medication nonadherence: A diagnosable and treatable medical condition
    • Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. JAMA 2013; 309: 2105-2106
    • (2013) Jama , vol.309 , pp. 2105-2106
    • Marcum, Z.A.1    Sevick, M.A.2    Handler, S.M.3
  • 63
    • 0018747749 scopus 로고
    • Guidelines for professionals
    • Patient behavior for blood pressure control
    • Patient behavior for blood pressure control. Guidelines for professionals. JAMA 1979; 241: 2534-2537
    • (1979) Jama , vol.241 , pp. 2534-2537
  • 64
    • 48249105871 scopus 로고    scopus 로고
    • Integration of depression and hypertension treatment: A pilot, randomized controlled trial
    • Bogner HR, de Vries HF. Integration of depression and hypertension treatment: a pilot, randomized controlled trial. Ann Fam Med 2008; 6: 295-301
    • (2008) Ann Fam Med , vol.6 , pp. 295-301
    • Bogner, H.R.1    De Vries, H.F.2
  • 65
    • 15944394816 scopus 로고    scopus 로고
    • Nurse administered telephone intervention for blood pressure control: A patient-tailored multifactorial intervention
    • Bosworth HB, Olsen MK, Gentry P, et al. Nurse administered telephone intervention for blood pressure control: a patient-tailored multifactorial intervention. Patient Educ Couns 2005; 57: 5-14
    • (2005) Patient Educ Couns , vol.57 , pp. 5-14
    • Bosworth, H.B.1    Olsen, M.K.2    Gentry, P.3
  • 66
    • 39149103069 scopus 로고    scopus 로고
    • Take control of your blood pressure (tcyb) study: A multifactorial tailored behavioral and educational intervention for achieving blood pressure control
    • Bosworth HB, Olsen MK, Neary A, et al. Take Control of Your Blood Pressure (TCYB) study: a multifactorial tailored behavioral and educational intervention for achieving blood pressure control. Patient Educ Couns 2008; 70: 338-347
    • (2008) Patient Educ Couns , vol.70 , pp. 338-347
    • Bosworth, H.B.1    Olsen, M.K.2    Neary, A.3
  • 67
    • 73249153446 scopus 로고    scopus 로고
    • Physician and pharmacist collaboration to improve blood pressure control
    • Carter BL, Ardery G, Dawson JD, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med 2009; 169: 1996-2002
    • (2009) Arch Intern Med , vol.169 , pp. 1996-2002
    • Carter, B.L.1    Ardery, G.2    Dawson, J.D.3
  • 68
    • 0029871819 scopus 로고    scopus 로고
    • A telecommunications system for monitoring and counseling patients with hypertension impact on medication adherence and blood pressure control
    • Friedman RH, Kazis LE, Jette A, et al. A telecommunications system for monitoring and counseling patients with hypertension. Impact on medication adherence and blood pressure control. Am J Hypertens 1996; 9: 285-292
    • (1996) Am J Hypertens , vol.9 , pp. 285-292
    • Friedman, R.H.1    Kazis, L.E.2    Jette, A.3
  • 69
    • 33846316038 scopus 로고    scopus 로고
    • Efficacy of a transtheoretical model-based expert system for antihypertensive adherence
    • Johnson SS, Driskell MM, Johnson JL, et al. Efficacy of a transtheoretical model-based expert system for antihypertensive adherence. Dis Manag 2006; 9: 291-301
    • (2006) Dis Manag , vol.9 , pp. 291-301
    • Johnson, S.S.1    Driskell, M.M.2    Johnson, J.L.3
  • 70
    • 5444264398 scopus 로고    scopus 로고
    • Nurse management for hypertension. A systems approach
    • Rudd P, Miller NH, Kaufman J, et al. Nurse management for hypertension. A systems approach. Am J Hypertens 2004; 17: 921-927
    • (2004) Am J Hypertens , vol.17 , pp. 921-927
    • Rudd, P.1    Miller, N.H.2    Kaufman, J.3
  • 71
    • 79957610344 scopus 로고    scopus 로고
    • Effectiveness of home telehealth in comorbid diabetes and hypertension: A randomized, controlled trial
    • Wakefield BJ, Holman JE, Ray A, et al. Effectiveness of home telehealth in comorbid diabetes and hypertension: a randomized, controlled trial. Telemed J E Health 2011; 17: 254-261
    • (2011) Telemed J e Health , vol.17 , pp. 254-261
    • Wakefield, B.J.1    Holman, J.E.2    Ray, A.3
  • 72
    • 0032162003 scopus 로고    scopus 로고
    • Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study
    • Solomon DK, Portner TS, Bass GE, et al. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998; 38: 574-585
    • (1998) J Am Pharm Assoc (Wash , vol.38 , pp. 574-585
    • Solomon, D.K.1    Portner, T.S.2    Bass, G.E.3
  • 73
    • 0036894205 scopus 로고    scopus 로고
    • Improving blood pressure control in a pharmacist-managed hypertension clinic
    • Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002; 22: 1533-1540
    • (2002) Pharmacotherapy , vol.22 , pp. 1533-1540
    • Vivian, E.M.1
  • 74
    • 33845450660 scopus 로고    scopus 로고
    • Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: A randomized controlled trial
    • Lee JK, Grace KA, Taylor AJ. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JAMA 2006; 296: 2563-2571
    • (2006) Jama , vol.296 , pp. 2563-2571
    • Lee, J.K.1    Grace, K.A.2    Taylor, A.J.3
  • 75
    • 32644445066 scopus 로고    scopus 로고
    • Effects of enhanced depression treatment on diabetes self-care
    • Lin EH, Katon W, Rutter C, et al. Effects of enhanced depression treatment on diabetes self-care. Ann Fam Med 2006; 4: 46-53
    • (2006) Ann Fam Med , vol.4 , pp. 46-53
    • Lin, E.H.1    Katon, W.2    Rutter, C.3
  • 76
    • 47749150662 scopus 로고    scopus 로고
    • Cardiovascular risk education and social support (caress): Report of a randomized controlled trial from the Kentucky ambulatory network (kan
    • Pearce KA, Love MM, Shelton BJ, et al. Cardiovascular risk education and social support (CaRESS): report of a randomized controlled trial from the Kentucky Ambulatory Network (KAN) J Am Board Fam Med 2008; 21: 269-281
    • (2008) J Am Board Fam Med , vol.21 , pp. 269-281
    • Pearce, K.A.1    Love, M.M.2    Shelton, B.J.3
  • 77
    • 0028884120 scopus 로고
    • Failure of educational videotapes to improve medication compliance in a health maintenance organization
    • Powell KM, Edgren B. Failure of educational videotapes to improve medication compliance in a health maintenance organization. Am J Health Syst Pharm 1995; 52: 2196-2199
    • (1995) Am J Health Syst Pharm , vol.52 , pp. 2196-2199
    • Powell, K.M.1    Edgren, B.2
  • 78
    • 38749110090 scopus 로고    scopus 로고
    • Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients
    • Schneider PJ, Murphy JE, Pedersen CA. Impact of medication packaging on adherence and treatment outcomes in older ambulatory patients. J Am Pharm Assoc (2003) 2008; 48: 58-63
    • (2008) J Am Pharm Assoc. 2003 , vol.48 , pp. 58-63
    • Schneider, P.J.1    Murphy, J.E.2    Pedersen, C.A.3
  • 79
    • 57249094301 scopus 로고    scopus 로고
    • A randomized controlled trial of team-based care: Impact of physician-pharmacist collaboration on uncontrolled hypertension
    • Hunt JS, Siemienczuk J, Pape G, et al. A randomized controlled trial of team-based care: impact of physician-pharmacist collaboration on uncontrolled hypertension. J Gen Intern Med 2008; 23: 1966-1972
    • (2008) J Gen Intern Med , vol.23 , pp. 1966-1972
    • Hunt, J.S.1    Siemienczuk, J.2    Pape, G.3
  • 80
    • 84897019266 scopus 로고    scopus 로고
    • Closing the quality gap: Revisiting the state of the science 4: Medication adherence interventions: Comparative effectiveness
    • Viswanathan M, Golin CE, Jones CD, et al. Closing the quality gap: revisiting the state of the science (vol. 4: medication adherence interventions: comparative effectiveness) Evid Rep Technol Assess (Full Rep) 2012; 4: 1-685
    • (2012) Evid Rep Technol Assess (Full Rep , vol.4 , pp. 1-685
    • Viswanathan, M.1    Golin, C.E.2    Jones, C.D.3
  • 81
    • 77952295236 scopus 로고    scopus 로고
    • Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications
    • Maciejewski ML, Bryson CL, Perkins M, et al. Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care 2010; 16: e20-e34
    • (2010) Am J Manag Care , vol.16 , pp. e20-e34
    • Maciejewski, M.L.1    Bryson, C.L.2    Perkins, M.3
  • 82
    • 77951620905 scopus 로고    scopus 로고
    • The impact of medicare part d on medication adherence among older adults enrolled in medicare-advantage products
    • Zhang Y, Lave JR, Donohue JM, et al. The impact of Medicare Part D on medication adherence among older adults enrolled in Medicare-Advantage products. Med Care 2010; 48: 409-417
    • (2010) Med Care , vol.48 , pp. 409-417
    • Zhang, Y.1    Lave, J.R.2    Donohue, J.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.